Literature DB >> 11078325

Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH.

D C Fahnoe1, J Knapp, G D Johnson, K Ahn.   

Abstract

Phosphoramidon has been shown to inhibit endothelin-converting enzyme-1 (ECE-1) in a remarkably pH-dependent manner (Ahn et al. Arch Biochem Biophys 1998;359:258-68). In order to determine whether this dramatic pH-dependence is a general phenomenon of ECE-1, two structurally unrelated ECE-1 inhibitors, PD 069185 and CGS 31447, were tested for ECE-1 inhibition at various pH values. Our data indicate that the potencies of these ECE-1 inhibitors are also highly affected by pH. ECE-1 is known to have a very sharp activity optimum at neutral pH which is in marked contrast to the acidic pH optimum for ECE-2. However, our results show that the pH optimum for ECE-1 activity is highly substrate-dependent. ECE-1 hydrolyzes the small peptide hormones bradykinin and substance P with acidic pH optima of 5.6-5.8, which sharply contrasts the neutral pH optimum with big ET-1 as substrate. These data suggest that the substrate preference for ECE-1 is highly affected by pH and that this pH-dependence for substrate preference might be one way of controlling the specificity of the enzyme in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078325     DOI: 10.1097/00005344-200036051-00009

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  13 in total

Review 1.  Targeting proteases in cardiovascular diseases by mass spectrometry-based proteomics.

Authors:  Diana Klingler; Markus Hardt
Journal:  Circ Cardiovasc Genet       Date:  2012-04-01

2.  Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay.

Authors:  Tanja Ouimet; Sou-Vinh Orng; Hervé Poras; Khatuna Gagnidze; Lakshmi A Devi; Marie-Claude Fournié-Zaluski; Bernard P Roques
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

3.  Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.

Authors:  Suqing Wang; Rui Wang; Lang Chen; David A Bennett; Dennis W Dickson; Deng-Shun Wang
Journal:  J Neurochem       Date:  2010-07-30       Impact factor: 5.372

4.  Endothelin-converting enzyme-1 degrades internalized somatostatin-14.

Authors:  Dirk Roosterman; Cordula Kempkes; Graeme S Cottrell; Benjamin E Padilla; Nigel W Bunnett; Christoph W Turck; Martin Steinhoff
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

5.  Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.

Authors:  Dirk Roosterman; Graeme S Cottrell; Benjamin E Padilla; Laurent Muller; Christopher B Eckman; Nigel W Bunnett; Martin Steinhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

6.  Endothelin-converting enzyme 1 promotes re-sensitization of neurokinin 1 receptor-dependent neurogenic inflammation.

Authors:  F Cattaruzza; G S Cottrell; N Vaksman; N W Bunnett
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

7.  Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.

Authors:  Nino Mzhavia; Hui Pan; Fa-Yun Che; Lloyd D Fricker; Lakshmi A Devi
Journal:  J Biol Chem       Date:  2003-01-30       Impact factor: 5.157

8.  Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells.

Authors:  Rui Wang; Suqing Wang; James S Malter; Deng-Shun Wang
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Structural analysis of Mycobacterium tuberculosis M13 metalloprotease Zmp1 open states.

Authors:  Wenguang G Liang; Jordan M Mancl; Minglei Zhao; Wei-Jen Tang
Journal:  Structure       Date:  2020-12-29       Impact factor: 5.006

10.  Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes.

Authors:  Javier Pacheco-Quinto; Dana Clausen; Rocío Pérez-González; Hui Peng; Austin Meszaros; Christopher B Eckman; Efrat Levy; Elizabeth A Eckman
Journal:  FASEB J       Date:  2018-11-27       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.